TABLE 4

Comparison of cell surface expression and signaling efficacy for each compound

Cells expressing WT or mutant hMC4Rs were preincubated in the absence or presence of 10 μM concentrations of the indicated compound for 12 h. After washes, cells expressing WT or mutant hMC4Rs were stimulated for 15 min at 37°C with 100 nM NDP-α-MSH.

Parameters and MutationsUntreatedMTHPPPPoneMPCIDCPMPNBP
Surface expression
    WT100172 ± 7135 ± 6144 ± 10189 ± 34192 ± 38
    S58C40 ± 5102 ± 4108 ± 474 ± 17184 ± 31229 ± 20
    E61K26 ± 337 ± 373 ± 1642 ± 7111 ± 273 ± 9
    N62S18 ± 847 ± 9130 ± 3237 ± 9165 ± 19138 ± 23
    I69T34 ± 1163 ± 16171 ± 3963 ± 7115 ± 1797 ± 8
    I125K105 ± 8204 ± 9114 ± 1689 ± 13186 ± 11217 ± 4
    T162I21 ± 261 ± 17132 ± 2374 ± 10134 ± 8113 ± 17
    R165Q16 ± 4208 ± 32344 ± 3188 ± 15278 ± 29277 ± 34
    R165W16 ± 586 ± 5104 ± 10116 ± 12283 ± 20294 ± 16
    C271Y24 ± 326 ± 0.559 ± 1069 ± 15105 ± 968 ± 13
Signaling
    WT100383 ± 41a330 ± 24a98 ± 9219 ± 23a44 ± 6
    S58C16 ± 2**34 ± 942 ± 924 ± 360 ± 12a10 ± 2
    E61K14 ± 2**4 ± 217 ± 313 ± 081 ± 5a12 ± 2
    N62S10 ± 3**13 ± 228 ± 3b14 ± 468 ± 4a10 ± 2
    I69T5 ± 1**42 ± 13b164 ± 25a18 ± 676 ± 14a25 ± 8
    I125K7 ± 1**6 ± 08 ± 07 ± 28 ± 212 ± 1
    T162I6 ± 1**16 ± 06 ± 133 ± 14102 ± 17a6 ± 1
    R165Q6 ± 0**97 ± 9a127 ± 32a56 ± 6a249 ± 54a36 ± 8b
    R165W3 ± 1**94 ± 21a115 ± 16a17 ± 1b205 ± 11a17 ± 1b
    C271Y4 ± 1**4 ± 110 ± 17 ± 332 ± 8a9 ± 4
Ratio
    WT12.232.440.681.160.23
    S58C0.400.330.390.320.330.04
    E61K0.540.110.230.310.730.16
    N62S0.560.280.220.380.410.07
    I69T0.150.670.960.290.660.26
    I125K0.070.030.070.080.040.06
    T162I0.290.260.050.450.760.05
    R165Q0.380.470.370.640.900.13
    R165W0.191.091.110.150.720.06
    C271Y0.170.150.170.10.30.13
  • a Significantly different from untreated condition, P < 0.01.

  • b Significantly different from untreated condition, P < 0.05.

  • ** Significantly different from untreated WT hMC4R, P < 0.01.